Literature DB >> 9065142

Mutations in mitochondrial transfer ribonucleic acid genes in preeclampsia.

T Folgerø1, N Storbakk, T Torbergsen, P Oian.   

Abstract

OBJECTIVE: We investigated whether maternally inherited mitochondrial deoxyribonucleic acid mutations could be associated with preeclampsia because mendelian models fail to explain all the aspects of inheritance in preeclampsia. STUDY
DESIGN: In two families with a high occurrence of preeclampsia and eclampsia the 22 mitochondrial transfer ribonucleic acid genes were sequenced in eight and three women, respectively.
RESULTS: An A-to-G mutation in transfer ribonucleic acidleu[UUR] at nucleotide 3243 was found in one family, and in the other there was an A-to-G mutation at nucleotide 12308 in transfer ribonucleic acidleu[CUN]. Mutations of mitochondrial transfer ribonucleic acid genes are generally considered to have systemic consequences, which might explain the multiorgan involvement seen in preeclampsia.
CONCLUSION: We report for the first time mutations in mitochondrial transfer ribonucleic acid genes in two families with a high occurrence of preeclampsia and eclampsia. Mitochondrial dysfunction caused by point mutations of mitochondrial deoxyribonucleic acid is maternally inherited, but in the case of mutations of nuclear genes mitochondrial dysfunction can be inherited as an autosomal recessive or dominant trait.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9065142     DOI: 10.1016/s0002-9378(96)70619-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Effects of taurine depletion on human placental syncytiotrophoblast renewal and susceptibility to oxidative stress.

Authors:  Michelle Desforges; Hannah Whittaker; Etaoin Farmer; Colin P Sibley; Susan L Greenwood
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

2.  Increased protein-coding mutations in the mitochondrial genome of African American women with preeclampsia.

Authors:  David Ding; Nicole M Scott; Emma E Thompson; Tinnakorn Chaiworapongsa; Raul Torres; Christine Billstrand; Kathleen Murray; Phillip J Dexheimer; Mahmoud Ismail; Helen Kay; Shawn Levy; Roberto Romero; Marshall D Lindheimer; Dan L Nicolae; Carole Ober
Journal:  Reprod Sci       Date:  2012-08-17       Impact factor: 3.060

3.  Fetal and maternal contributions to risk of pre-eclampsia: population based study.

Authors:  R T Lie; S Rasmussen; H Brunborg; H K Gjessing; E Lie-Nielsen; L M Irgens
Journal:  BMJ       Date:  1998-05-02

4.  Hypertension in pregnancy: new recommendations for management.

Authors:  R Shear; L Leduc; E Rey; J M Moutquin
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

Review 5.  Mitochondrial disease in pregnancy: a systematic review.

Authors:  R E Say; R G Whittaker; H E Turnbull; R McFarland; R W Taylor; D M Turnbull
Journal:  Obstet Med       Date:  2011-06-23

6.  Mitochondrial tRNA(leu)(UUR) gene mutation and the decreased activity of cytochrome c oxidase in preeclampsia.

Authors:  Z Wang; G Zhang; M Lin
Journal:  J Tongji Med Univ       Date:  1999

7.  Paradox of schizophrenia genetics: is a paradigm shift occurring?

Authors:  Nagafumi Doi; Yoko Hoshi; Masanari Itokawa; Takeo Yoshikawa; Tomoe Ichikawa; Makoto Arai; Chie Usui; Hirokazu Tachikawa
Journal:  Behav Brain Funct       Date:  2012-05-31       Impact factor: 3.759

Review 8.  Mitochondria and Coenzyme Q10 in the Pathogenesis of Preeclampsia.

Authors:  Enrique Teran; Isabel Hernández; Leandro Tana; Santiago Teran; Carlos Galaviz-Hernandez; Martha Sosa-Macías; Gustavo Molina; Andrés Calle
Journal:  Front Physiol       Date:  2018-11-15       Impact factor: 4.566

9.  Two variants of the C-reactive protein gene are associated with risk of pre-eclampsia in an American Indian population.

Authors:  Lyle G Best; Richa Saxena; Cindy M Anderson; Michael R Barnes; Hakon Hakonarson; Gilbert Falcon; Candelaria Martin; Berta Almoguera Castillo; Ananth Karumanchi; Kylie Keplin; Nichole Pearson; Felicia Lamb; Shellee Bercier; Brendan J Keating
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.